2010 BIO International Convention to discuss issues that impact drug discovery and development

Download PDF Copy

Mar 31 2010

The 2010 BIO International Convention will feature a robust health and medical program highlighting the latest scientific breakthroughs and policy and business development issues that impact drug discovery and development. Hosted by the Biotechnology Industry Organization, the Convention will be held May 3-6, 2010 in Chicago, Ill. at McCormick Place.

“The biotechnology community is constantly finding innovations that may someday treat or cure the most prevalent diseases, such as HIV/AIDS, cancer and malaria as well as numerous orphan diseases that affect smaller patient populations.”

"This year's program showcases recent scientific advancements as well as the business and regulatory issues that allow our industry to extend and improve the health and lives of people around the globe," said Jim Greenwood, BIO's President and CEO. "The biotechnology community is constantly finding innovations that may someday treat or cure the most prevalent diseases, such as HIV/AIDS, cancer and malaria as well as numerous orphan diseases that affect smaller patient populations."

The program includes historically popular tracks like Biomarkers and Drug Discovery and Development as well as new tracks for 2010 such as Delivery & Manufacturing of Biologics & Drugs, Global Drug Development and Marketing and Innovations in Vaccines.

A sample of breakout sessions includes:

Therapeutic Cancer Vaccines - From Biological Complexity to Novel Patient Solutions
Monday, May 3, 2:00 p.m. - 3:30 p.m.
Speakers Include: Jens Oliver Funk, M.D., EMD Serono, Inc.; Wayne Godfrey, BN ImmunoTherapeutics, Inc.; Jeffrey Schlom, Ph.D., National Cancer Institute; Helen Sabzevari, National Cancer Institute; Mark Frohlich, M.D., Dendreon
Commercialization of Biomarkers: From Discovery to Medical Diagnostics
Monday, May 3, 4:00 p.m. - 5:30 p.m.
Speakers include: Tim Clark, Piper Alderman; Christopher Boyle, Bio-Link; Michael Henry, Athena Diagnostics
Build or Buy? Strategic Choices in Biomanufacturing
Tuesday, May 4, 2:00 p.m. - 3:30 p.m.
Speakers Include: Anne Montgomery, BioProcess International; Laura Bush, Advanstar Communications; Parrish Galliher, M.S., Xcellerex, Inc; Steven Lee, Ph.D., A-Bio Pharma Pte Ltd.; Alain Pralong, Crucell NV; Eric Langer, Ph.D., BioPlan Associates, Inc.
Vaccines for the 21^st Century
Tuesday, May 4, 2:00 p.m. - 3:30 p.m.
Speakers Include: Jeff Swarz, Ph.D., Caris and Company; Joe Shaw, Syntiron; Gavin Zealey, MBA, sanofi Pasteur; Vijay Samant, Ph.D., Vical Inc.; Jan ter Meulen, M.D., Merck; James Jackson, Ph.D., Emergent BioSolutions, Inc.
It's Personal - Transforming Health Care through Personalized Medicine
Tuesday, May 4, 4:00 p.m. - 5:30 p.m.
Speakers Include: Edward Abrahams, Ph.D., Personalized Medicine Coalition; Linh Hoang, M.D., Life Technologies; Laura Shawver, Ph.D., The Clearity Foundation; Felix Frueh, MEDCO; Nicholas Dracapoli, Johnson & Johnson Pharmaceuticals
Pandemic Preparedness: Therapeutics Policy and Deployment
Wednesday May 5, 10:00 a.m. - 11:30 a.m.
FDA Town Hall
Wednesday, May 5, 10:00 a.m. - 11:30 a.m.
Speakers Include: Douglas Throckmorton, M.D., U.S. Food and Drug Administration, Center for Drug Evaluation and Research; Karen Midthun, MD, U.S. Food and Drug Administration, Center for Biologics Evaluation and Research

The annual BIO International Convention helps to support the association's programs and initiatives. BIO works throughout the year to create a policy environment that enables the industry to continue to fulfill its vision of bettering the world through biotechnology innovation.

Additional Upcoming BIO Events

BIO Legislative Day Fly-In 2010
April 13-14, 2010
Washington, DC